Notis McConarty Edward boosted its stake in Colgate-Palmolive Company (NYSE:CL) by 8.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,819 shares of the company’s stock after acquiring an additional 1,269 shares during the period. Notis McConarty Edward’s holdings in Colgate-Palmolive were worth $1,173,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Chickasaw Capital Management LLC raised its holdings in Colgate-Palmolive by 218.3% during the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after purchasing an additional 11,605 shares in the last quarter. Meritage Portfolio Management grew its position in Colgate-Palmolive by 0.3% during the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock worth $7,017,000 after buying an additional 255 shares during the period. Alliancebernstein L.P. grew its position in Colgate-Palmolive by 4.2% during the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock worth $139,014,000 after buying an additional 77,414 shares during the period. Israel Discount Bank of New York acquired a new position in Colgate-Palmolive during the first quarter worth about $1,349,000. Finally, ProShare Advisors LLC grew its position in Colgate-Palmolive by 9.9% during the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock worth $64,382,000 after buying an additional 79,323 shares during the period. 73.16% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company (NYSE CL) traded up 0.01% during mid-day trading on Friday, hitting $72.15. 2,664,624 shares of the company’s stock were exchanged. The firm has a 50 day moving average of $71.59 and a 200 day moving average of $73.29. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The stock has a market capitalization of $63.55 billion, a P/E ratio of 26.81 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s revenue for the quarter was down .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.70 EPS. Equities analysts forecast that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
Several research firms have recently commented on CL. Bank of America Corporation increased their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 31st. BidaskClub lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research report on Thursday, May 25th. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research note on Tuesday, July 4th. Finally, Jefferies Group LLC increased their price target on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a research note on Thursday, July 6th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $75.83.
COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive Company (CL) Stake Raised by Notis McConarty Edward” was reported by BBNS and is the property of of BBNS. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://baseballnewssource.com/markets/colgate-palmolive-company-cl-shares-bought-by-notis-mcconarty-edward/1605342.html.
In other news, CFO Dennis J. Hickey sold 73,872 shares of the stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the completion of the transaction, the chief financial officer now owns 484,985 shares in the company, valued at approximately $34,821,923. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the sale, the insider now directly owns 53,173 shares in the company, valued at approximately $3,799,210.85. The disclosure for this sale can be found here. Insiders sold a total of 217,969 shares of company stock valued at $15,693,933 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with our FREE daily email newsletter.